CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300888 Winner Medical
- 52.22
- +0.14+0.27%
Market Closed Apr 30 15:00 CST
30.41BMarket Cap39.92P/E (TTM)
54.80High51.32Low75.00KlotVolume52.08Open52.08Pre Close400.20MTurnover4.27%Turnover Ratio43.74P/E (Static)582.33MShares54.8052wk High2.66P/B9.16BFloat Cap22.9152wk Low62.50Limit Up175.51MShs Float151.96Historical High41.66Limit Down6.68%Amplitude22.91Historical Low0.90Dividend TTM53.36Avg Price36.47KlotAsk1.72%Div YieldTTM100Lot Size32.57KlotBid
Winner Medical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -66.29%1.26B | -69.99%1.41B | 1.41%3.92B | -9.80%3.92B | -14.42%3.75B | 3.96%4.71B | 0.85%3.86B | 3.07%4.34B | 13.92%4.38B | 5.92%4.53B |
| Transactional financial assets | -10.35%2.27B | 2.50%2.92B | -51.79%1.79B | -30.33%2.52B | -40.67%2.53B | -34.91%2.85B | 9.20%3.71B | 32.88%3.62B | 22.80%4.26B | 39.87%4.38B |
| Notes receivable and accounts receivable | 25.17%1.15B | 25.06%1.01B | 39.32%1.15B | 15.60%952.27M | 1.00%917.82M | -17.49%811.57M | -10.67%826.25M | -17.85%823.75M | -2.76%908.7M | 26.83%983.64M |
| -Notes receivable | -11.60%28.42M | -20.12%34.32M | -12.90%22.99M | -43.71%13.04M | 1.59%32.15M | -15.76%42.96M | --26.39M | --23.16M | --31.65M | --51M |
| -Accounts receivable | 26.51%1.12B | 27.58%980.62M | 41.04%1.13B | 17.32%939.23M | 0.98%885.67M | -17.59%768.6M | -13.52%799.85M | -20.16%800.59M | -6.14%877.05M | 20.26%932.64M |
| Other receivables (including interest and dividends) | -17.35%191.56M | -14.87%186.35M | -52.71%252.58M | 2.39%225.81M | 2.70%231.78M | -7.36%218.91M | 62.85%534.15M | -31.47%220.54M | -29.11%225.69M | -28.22%236.3M |
| -Other receivable | ---- | ---- | ---- | 2.39%225.81M | ---- | ---- | ---- | -31.47%220.54M | ---- | -28.22%236.3M |
| Advance payment | 68.63%200.63M | -12.45%107.05M | -12.22%134.82M | -16.56%112.98M | -50.04%118.98M | -46.65%122.28M | -25.50%153.58M | -67.82%135.41M | 59.11%238.12M | 107.51%229.23M |
| Inventories | 34.05%1.96B | 36.50%1.96B | 35.66%1.99B | 2.79%1.45B | 0.22%1.46B | -7.99%1.43B | -22.21%1.47B | -21.85%1.41B | -11.29%1.46B | -2.41%1.56B |
| Receivable financing | -5.78%32.4M | 132.89%68.35M | 75.44%52.44M | -5.02%36.36M | -47.56%34.39M | -68.47%29.35M | -63.43%29.89M | 28.58%38.28M | 124.42%65.59M | 836.52%93.09M |
| Non-current assets due within one year | 7,703.29%348.05M | 7,788.65%345.47M | --4.42M | --4.5M | --4.46M | --4.38M | ---- | --0 | ---- | ---- |
| Other current assets | -77.83%81.42M | -82.12%67.74M | 18.53%208.89M | 3.94%182.63M | 135.03%367.24M | 218.21%378.85M | 23.43%176.23M | 51.36%175.7M | 5.08%156.25M | 0.25%119.06M |
| Total current assets | -20.42%7.49B | -23.44%8.08B | -11.73%9.5B | -12.66%9.41B | -19.51%9.42B | -12.95%10.56B | -0.34%10.76B | 1.25%10.77B | 10.96%11.7B | 17.21%12.13B |
| Non Current assets | ||||||||||
| Other non-current financial assets | 54.00%107.8M | 54.15%107.91M | 48.76%104.13M | 0.00%70M | 75.00%70M | 75.00%70M | --70M | --70M | --40M | --40M |
| Investment real estate | -71.24%2.14M | -69.32%2.36M | -13.30%6.9M | -12.87%7.17M | -12.28%7.43M | -12.05%7.69M | 94.22%7.96M | --8.22M | --8.47M | --8.75M |
| Long-term equity investment | -2.24%438.96M | 2,033.01%445.36M | 1,869.05%438.49M | 1,791.49%441.26M | 1,879.13%449.01M | -3.99%20.88M | 11.10%22.27M | 20.51%23.33M | 25.01%22.69M | 28.31%21.75M |
| Long term receivable account | 145.09%88.61M | 147.79%88.44M | --30.79M | --36.66M | --36.15M | --35.69M | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | ---- | ---- | 22.89%2.9B | ---- | ---- | ---- | 22.76%2.36B | ---- | 56.57%2.31B |
| Constru in process | ---- | ---- | ---- | 1.25%1.03B | ---- | ---- | ---- | 91.39%1.02B | ---- | 254.01%765.01M |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Intangible assets | 9.47%1.07B | 10.10%1.1B | -6.39%983.15M | -6.39%960.82M | -3.71%979.23M | -3.67%995.23M | 19.59%1.05B | 28.46%1.03B | 242.18%1.02B | 288.82%1.03B |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Goodwill | 44.77%1.25B | 44.77%1.25B | 42.68%1.51B | -17.76%866.5M | -17.27%864.29M | -17.27%864.29M | 7.15%1.06B | 78.91%1.05B | --1.04B | --1.04B |
| Long deferred expense | 8.58%133.9M | 9.74%143.86M | -5.68%129.61M | 8.10%125.41M | 0.47%123.31M | -1.21%131.09M | -13.03%137.41M | -25.56%116.02M | -27.52%122.74M | -24.08%132.69M |
| Deferred tax assets | -20.75%135.25M | -20.73%139M | -37.01%176.7M | -42.89%161.72M | -46.30%170.66M | -17.28%175.35M | 102.92%280.51M | 107.44%283.16M | 151.44%317.79M | 72.73%211.97M |
| Usufruct assets | 40.37%553.76M | 42.57%595.22M | 41.34%571.3M | 1.25%421.82M | -7.69%394.5M | -11.61%417.5M | -15.55%404.19M | -12.04%416.59M | -11.49%427.36M | -11.17%472.36M |
| Other non current assets | 2,058.38%2.03B | 1,819.10%2.01B | -89.09%191.48M | -2.13%133.87M | -30.36%94.11M | 25.54%104.86M | 1,397.33%1.76B | -45.79%136.79M | -11.65%135.13M | -27.73%83.52M |
| Total non current assets | 45.46%10.29B | 57.27%10.31B | 0.58%8.34B | 9.89%7.16B | 11.82%7.08B | 7.01%6.56B | 45.55%8.3B | 33.44%6.51B | 105.33%6.33B | 109.76%6.13B |
| Total assets | 7.84%17.79B | 7.48%18.39B | -6.37%17.84B | -4.16%16.57B | -8.51%16.49B | -6.25%17.11B | 15.52%19.06B | 11.38%17.29B | 32.31%18.03B | 37.58%18.25B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 48.21%1.8B | 31.86%1.97B | 31.33%1.76B | -33.62%1.17B | -49.94%1.21B | -34.94%1.49B | -29.68%1.34B | 54.45%1.76B | 2,323.36%2.42B | --2.3B |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Notes payable and accounts payable | 1.34%1.29B | 10.83%1.59B | 53.78%1.49B | 34.16%1.2B | 45.33%1.27B | 25.20%1.43B | 19.85%967.41M | -21.98%891.8M | 0.04%872.65M | 48.48%1.14B |
| -Notes payable | 8.39%383.21M | 36.71%431.87M | 162.43%537.04M | 322.25%363.98M | 1,327.85%353.54M | 1,175.86%315.9M | 484.35%204.64M | -40.99%86.2M | -86.73%24.76M | -31.60%24.76M |
| -Accounts payable | -1.39%902.04M | 3.50%1.16B | 24.63%950.67M | 3.33%832.42M | 7.88%914.73M | -0.25%1.12B | -1.22%762.77M | -19.19%805.6M | 23.65%847.89M | 52.42%1.12B |
| Contract liabilities | -0.82%178.85M | -5.44%182.76M | -14.99%179.64M | -24.84%179.91M | -23.89%180.33M | -65.90%193.26M | -34.18%211.33M | -25.38%239.36M | -42.16%236.92M | 66.14%566.82M |
| Salaries payable | 10.66%204.51M | 21.41%308.96M | 16.62%264.6M | 6.49%216.82M | 1.82%184.81M | -18.55%254.48M | -5.70%226.89M | -5.86%203.6M | 21.87%181.5M | 69.18%312.45M |
| Taxs payable | 74.09%116.49M | 96.62%123.63M | 134.69%122.96M | 10.31%93.25M | -64.75%66.91M | -80.49%62.88M | -66.74%52.39M | -53.93%84.54M | 13.64%189.82M | 243.34%322.26M |
| Other payable (including interest and dividends) | 27.03%610.47M | 15.23%681.39M | -28.50%727.9M | -20.75%727.22M | 3.96%480.59M | 3.59%591.31M | 134.09%1.02B | 103.07%917.66M | 19.61%462.26M | 28.58%570.84M |
| -Dividend payable | --116.37M | --164.87M | -71.30%162.65M | -64.12%203.31M | ---- | ---- | --566.64M | --566.64M | ---- | ---- |
| -Other payable | ---- | ---- | ---- | 49.26%523.92M | ---- | ---- | ---- | -22.32%351.01M | ---- | 28.58%570.84M |
| Non current liabilities due within one year | -2.22%204.67M | 77.58%396.77M | 37.64%372.5M | 95.00%373.94M | 22.35%209.31M | 3.46%223.43M | 26.95%270.62M | -13.15%191.76M | -22.56%171.08M | -0.11%215.95M |
| Other current liabilities | 58.02%22.12M | 7.72%21.24M | 6.89%17.43M | -4.71%18.51M | -41.60%14M | -66.93%19.71M | -33.74%16.3M | -28.17%19.43M | -36.65%23.97M | 146.65%59.6M |
| Total current liabilities | 22.20%4.42B | 23.43%5.27B | 20.23%4.94B | -7.77%3.98B | -20.70%3.62B | -22.17%4.27B | -0.07%4.11B | 16.37%4.31B | 94.68%4.56B | 164.49%5.49B |
| Current liabilities | ||||||||||
| Long term loan | -68.73%53.15M | -68.82%53M | -58.40%70.72M | ---- | -15.00%170M | --170M | 2,025.00%170M | 542.86%180M | --200M | ---- |
| Long term salaries pay | 52.19%13.67M | 55.66%13.25M | 48.96%12.78M | -0.80%8.51M | 12.83%8.98M | -0.80%8.51M | -7.78%8.58M | -7.78%8.58M | --7.96M | --8.58M |
| Deferred tax liabilities | 16.64%158.23M | 14.43%158.52M | -73.18%128.36M | -43.44%132.2M | -42.48%135.66M | 3.62%138.52M | 360.64%478.67M | 191.51%233.73M | 1,679.96%235.86M | 902.29%133.68M |
| Long term deferred income | 35.43%160.36M | 29.19%157.15M | 17.24%157.95M | -7.97%116.53M | 8.48%118.41M | 23.14%121.65M | 38.85%134.73M | 27.63%126.61M | 5.61%109.15M | -9.88%98.79M |
| Lease liabilities | 44.58%409.31M | 50.98%440.88M | 63.17%456.15M | 0.07%304.17M | -11.37%283.1M | -10.55%292.01M | -15.19%279.56M | -3.97%303.95M | -2.12%319.41M | -14.50%326.46M |
| Other non current liabilities | --373.26M | --373.26M | ---- | ---- | ---- | ---- | --221.32M | ---- | ---- | ---- |
| Total non current liabilities | 70.69%1.22B | 70.33%1.24B | -36.11%825.97M | -34.17%561.41M | -17.91%716.15M | 28.75%730.69M | 135.98%1.29B | 59.95%852.87M | 96.95%872.38M | 12.43%567.51M |
| Total liabilities | 30.21%5.64B | 30.28%6.52B | 6.74%5.76B | -12.13%4.54B | -20.25%4.33B | -17.40%5B | 15.93%5.4B | 21.85%5.16B | 95.04%5.43B | 134.73%6.05B |
| Shareholders equity | ||||||||||
| Paid-in capital | -1.01%582.33M | -2.03%582.33M | -1.03%588.29M | -1.03%588.29M | 37.94%588.29M | 39.37%594.39M | 39.37%594.39M | 39.37%594.39M | 0.00%426.49M | 0.00%426.49M |
| Capital reserve funds | -13.84%3.39B | -22.88%3.38B | -10.03%3.94B | -10.06%3.94B | -13.59%3.94B | -3.63%4.38B | -5.06%4.38B | -4.63%4.38B | -0.31%4.56B | -0.07%4.55B |
| Surplus reserve funds | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M | 0.00%420.21M |
| Retained profit | 3.50%7.03B | 2.59%6.78B | -18.82%6.64B | -0.13%6.7B | -5.72%6.79B | -3.18%6.61B | 27.54%8.18B | 10.85%6.71B | 22.18%7.2B | 23.25%6.83B |
| Less:Treasury stock | -95.65%7.28M | -98.46%7.28M | -54.21%216.86M | -56.54%217.31M | -66.54%167.32M | -5.31%473.55M | -5.31%473.55M | 0.00%500.08M | 3.65%500.08M | 93.84%500.08M |
| Other composite income | -269.00%-4.76M | -219.07%-2.64M | -442.41%-6.68M | -130.52%-716.17K | 670.05%2.81M | 183.01%2.22M | 328.90%1.95M | 443.69%2.35M | 121.73%365.55K | 150.28%782.78K |
| Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Shareholders equity without minority interests | -1.39%11.41B | -3.31%11.15B | -13.25%11.36B | -1.51%11.43B | -4.41%11.57B | -1.59%11.53B | 15.20%13.1B | 5.60%11.61B | 11.81%12.11B | 9.79%11.72B |
| Minority interests | 24.71%734.07M | 25.52%724.39M | 28.13%718.43M | 15.83%599.84M | 20.41%588.62M | 20.69%577.1M | 19.05%560.72M | 76.56%517.88M | 3,791.64%488.86M | 3,820.62%478.16M |
| Total shareholder equity | -0.13%12.15B | -1.94%11.88B | -11.55%12.08B | -0.77%12.03B | -3.45%12.16B | -0.72%12.11B | 15.35%13.66B | 7.44%12.12B | 16.18%12.6B | 14.14%12.2B |
| Total liabilityies and equity | 7.84%17.79B | 7.48%18.39B | -6.37%17.84B | -4.16%16.57B | -8.51%16.49B | -6.25%17.11B | 15.52%19.06B | 11.38%17.29B | 32.31%18.03B | 37.58%18.25B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.